Safety of Hydroxychloroquine, Alone and in Combination With Azithromycin, in Light of Rapid Wide-Spread Use for COVID-19: A Multinational, Network Cohort and Self-Controlled Case Series Study

doi 10.1101/2020.04.08.20054551
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Chloroquine and Hydroxychloroquine in Covid-19

British Medical Journal
Medicine
2020English

Does COVID-19 Spread Through Droplets Alone?

Frontiers in Public Health
EnvironmentalPublic HealthOccupational Health
2020English

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Preliminary Results of an Open-Label Non-Randomized Clinical Trial

2020English

Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Safety Considerations With Chloroquine, Hydroxychloroquine and Azithromycin in the Management of SARS-CoV-2 Infection

CMAJ
Medicine
2020English

Repurposing of Chloroquine and Its Derivative, Hydroxychloroquine for COVID-19: Implications for People Living With HIV in Africa

2020English

Projected Early Spread of COVID-19 in Africa

2020English

Clinical Characteristics and Durations of Hospitalized Patients With COVID-19 in Beijing: A Retrospective Cohort Study

2020English

Clinical and Virological Data of the First Cases of COVID-19 in Europe: A Case Series

The Lancet Infectious Diseases
Infectious Diseases
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy